GB201904771D0 - New pharmaceutical compositions - Google Patents
New pharmaceutical compositionsInfo
- Publication number
- GB201904771D0 GB201904771D0 GBGB1904771.1A GB201904771A GB201904771D0 GB 201904771 D0 GB201904771 D0 GB 201904771D0 GB 201904771 A GB201904771 A GB 201904771A GB 201904771 D0 GB201904771 D0 GB 201904771D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compositions
- new pharmaceutical
- new
- compositions
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1904771.1A GB201904771D0 (en) | 2019-04-04 | 2019-04-04 | New pharmaceutical compositions |
| PCT/GB2020/050892 WO2020201768A1 (en) | 2019-04-04 | 2020-04-03 | Pharmaceutical compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1904771.1A GB201904771D0 (en) | 2019-04-04 | 2019-04-04 | New pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201904771D0 true GB201904771D0 (en) | 2019-05-22 |
Family
ID=66809533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1904771.1A Ceased GB201904771D0 (en) | 2019-04-04 | 2019-04-04 | New pharmaceutical compositions |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201904771D0 (en) |
| WO (1) | WO2020201768A1 (en) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9516268D0 (en) | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
| FR2753376B1 (en) * | 1996-09-18 | 1998-10-16 | Synthelabo | PHARMACEUTICAL COMPOSITIONS COMPRISING AMISULPRIDE AND THERAPEUTIC APPLICATIONS THEREOF |
| CN1826100B (en) | 2003-07-17 | 2010-12-22 | 旗帜药物胶囊公司 | Controlled release preparation |
| SI1765292T1 (en) | 2004-06-12 | 2018-04-30 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
| US20080286373A1 (en) | 2007-05-18 | 2008-11-20 | Palepu Nageswara R | Ziprasidone formulations |
| RU2678833C2 (en) | 2008-09-17 | 2019-02-04 | Киазма Инк. | Pharmaceutical compositions and related delivery methods |
| US20110142889A1 (en) | 2009-12-16 | 2011-06-16 | Nod Pharmaceuticals, Inc. | Compositions and methods for oral drug delivery |
| EP3160444B1 (en) | 2014-06-25 | 2021-11-24 | Synergia Bio Sciences Private Limited | A pharmaceutical oil-in-water nano-emulsion |
| CA2910865C (en) | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
| US10265384B2 (en) | 2015-01-29 | 2019-04-23 | Novo Nordisk A/S | Tablets comprising GLP-1 agonist and enteric coating |
| CN105395493B (en) * | 2015-11-20 | 2018-02-16 | 南京正科医药股份有限公司 | A kind of lurasidone hydrochloride tablet |
| US20170312226A1 (en) | 2016-04-28 | 2017-11-02 | Ascent Pharmaceuticals, Inc. | Pharmaceutical dosage forms |
| US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
| CN106822042A (en) * | 2017-01-24 | 2017-06-13 | 广州帝奇医药技术有限公司 | A kind of risperidone slow-release composition and preparation method thereof |
| CN107875122A (en) | 2017-12-17 | 2018-04-06 | 佛山市弘泰药物研发有限公司 | A kind of Lurasidone HCl self-micro emulsion formulation and preparation method thereof |
| WO2019128991A1 (en) | 2017-12-26 | 2019-07-04 | Sunshine Lake Pharma Co., Ltd. | Lurasidone solid dispersion and preparation method thereof |
-
2019
- 2019-04-04 GB GBGB1904771.1A patent/GB201904771D0/en not_active Ceased
-
2020
- 2020-04-03 WO PCT/GB2020/050892 patent/WO2020201768A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020201768A1 (en) | 2020-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201916960D0 (en) | Compositions | |
| DK3924442T3 (en) | Compositions | |
| GB201911517D0 (en) | Pharmaceutical composition | |
| GB201807053D0 (en) | Pharmaceutical composition | |
| IL290469A (en) | Oral pharmaceutical composition | |
| GB201908396D0 (en) | Compositions | |
| ZA202006541B (en) | Pharmaceutical composition comprising brexpiprazole | |
| GB201804548D0 (en) | Pharmaceutical compositions | |
| PL3908321T3 (en) | Pharmaceutical composition | |
| GB201808571D0 (en) | Pharmaceutical compositions | |
| IL285728A (en) | Pharmaceutical composition | |
| GB201808567D0 (en) | Pharmaceutical compositions | |
| IL285389A (en) | Pharmaceutical compositions comprising meloxicam | |
| SG11202110315SA (en) | Pharmaceutical composition | |
| SG11202103374TA (en) | Pharmaceutical composition | |
| EP3914234A4 (en) | Pharmaceutical compositions | |
| IL289927A (en) | New pharmaceutical formulation | |
| PL4027974T3 (en) | Pharmaceutical composition containing p-boronophenylalanine | |
| GB201916122D0 (en) | New compositions | |
| GB201919234D0 (en) | Compositions | |
| GB201904771D0 (en) | New pharmaceutical compositions | |
| GB201904783D0 (en) | New pharmaceutical compositions | |
| GB201904785D0 (en) | New pharmaceutical compositions | |
| GB201904767D0 (en) | New pharmaceutical compositions | |
| GB201912686D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |